Pfizer Promoting Tiered Drug Coverage Policy For Middle-Income Nations
This article was originally published in PharmAsia News
Executive Summary
Pfizer is advocating a new U.S. trade stance toward setting parameters around foreign governments' drug reimbursement policies in middle-income nations